BIO-key International, Inc.
corporate_fare Company Profile
BIO-key International, Inc. (NASDAQ:BKYI) is a publicly traded company in the Technology sector. Wiseek has independently scored 37 items for BKYI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for BKYI spans 10-Q, S-1/A, S-1, 8-K.
Recent high-impact activity:
- BIO-key Q3: $4.01/Share Loss, Going-Concern Warning, Ineffective Controls
- BIO-key Posts $4.01 Per-Share Q3 Loss
- BIO-key Clears Final Hurdle: 1.24M Armistice Warrants Now Exercisable After Oct 30 Vote
- BIO-key Registers 1.24M Warrant Shares for Resale After Stockholder Vote Fails
- BIO-key Retires $416K Secured Note by Issuing 247,805 Shares to Streeterville
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 270,717 shares in BKYI as of the October 30, 2026 settlement, a 29.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 23.2% of BKYI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BKYI, detected from its recent SEC filings · based on capital-structure filings through 2026-10-02.
Debt-for-Equity Exchange Retires Secured Note · Immediate Resale Risk
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →